Cytokinetics Inc. buy Citigroup Inc.
Start price
22.12.25
/
50%
€55.50
Target price
22.12.26
-
Performance (%)
-3.60%
Price
23.12.25
€53.50
Summary
This prediction is currently active. With a performance of -3.60%, the BUY prediction by Citigroup_Inc_ is trending in the wrong direction. This prediction currently runs until 22.12.26. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Cytokinetics Inc. | -3.60% |
| iShares Core DAX® | 0.224% |
| iShares Nasdaq 100 | 0.371% |
| iShares Nikkei 225® | 0.972% |
| iShares S&P 500 | 0.417% |
Comments by Citigroup_Inc_ for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics (NASDAQ:CYTK) had its "outperform" rating reaffirmed by analysts at Citigroup Inc..
Ratings data for CYTK provided by MarketBeat
Stopped prediction by Citigroup_Inc_ for Cytokinetics Inc.
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€41.80
02.09.25
02.09.25
€71.78
02.09.26
02.09.26
27.99%
23.12.25
23.12.25
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€29.40
07.05.25
07.05.25
€70.52
07.05.26
07.05.26
81.97%
23.12.25
23.12.25
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€43.80
07.02.25
07.02.25
€82.96
07.02.26
07.02.26
22.15%
23.12.25
23.12.25